The role of carotid body in brain insulin resistance and neurodegeneration / Adriana Margarida Mateus Capucho ; orient. Sílvia Vilares Conde, Hugo Vicente Miranda
Main Author Capucho, Adriana Margarida Mateus Secondary Author Conde, Sílvia VilaresMiranda, Hugo Vicente Publication Lisboa : NOVA Medical School, 2022 Description xxiv, 93 p. : il., fig. Abstract Recent epidemiological studies have shown that individuals who develop Type 2 Diabetes (T2D) at an early age have an increased risk to develop neurodegenerative disorders, as Alzheimer’s (AD) and Parkinson’s Disease (PD). A common characteristic between T2D and these neurodegenerative disorders is the development of an insulin resistance state. Considering that the therapeutics that exists to neurodegenerative disorders only attenuate the symptoms and have several side effects, it is important to search for novel disease modifying therapies. Recently, Conde’s group showed that in states of insulin resistance, glucose intolerance and obesity, features associated with T2D, the carotid bodies (CBs) were overactivated. The CBs are peripheral chemoreceptors classically defined as oxygen sensors, and in the last years they havebeen described as metabolic sensors. Moreover, when CBs activity was abolished via the resection of the carotid sinus nerve (CSN), which transmits the information from the CBs to the brain, T2D dysmetabolic features were reverted. Considering that dysmetabolism is a risk factor to the development of neurodegenerative disorders, the main goal of this project was to investigate if the abolishment of CBs activity via bilateral resection of the CSN could prevent/ameliorate the neurodegenerative process, and cognitive impairment associated with brain insulin resistance. For that, we have used an animal model of dysmetabolism, the high fat-high sucrose (HFHSu) diet animal and tested the effect of the abolishment of CBs activity, through the resection of the CSN, on whole-body glucose metabolism and on the behavioural activity of the animals. Moreover, the levels of insulin signalling- related proteins, synaptic and neurodegenerative markers in prefrontal cortex and in the hippocampus were evaluated. We observed that the HFHSu animals exhibited impaired cognitive and olfactory functionsevaluated by the y-maze and the block tests. In contrast, the CSN resection prevented this phenotype in the y-maze test. Additionally, HFHSu diet led to an increase in the levels of advanced glycation end products (AGEs), and the amyloid precursor protein (APP) in the hippocampus, while the CSN resection attenuating this second effect. In the prefrontal cortex, it was observed an increase in the levels of alpha-synuclein (aSyn), and APP, effects abolished by CSN resection. In conclusion, this project demonstrate that CBs modulation might have a role in preventing neurodegenerative processes associated with insulin resistance. Topical name Neurodegenerative Disorders
Diabetes Mellitus - Type 2
Academic Dissertation
Portugal Index terms Dissertação de Mestrado
Investigação Biomédica
Universidade NOVA de Lisboa
NOVA Medical School
2022 CDU 616 Online Resources Click here to access the eletronic resource http://hdl.handle.net/10362/134133
| Item type | Current location | Call number | url | Status | Date due | Barcode |
|---|---|---|---|---|---|---|
| Documento Eletrónico | Biblioteca NMS|FCM online | RUN | http://hdl.handle.net/10362/134133 | Available | 20220044 |
Recent epidemiological studies have shown that individuals who develop Type 2 Diabetes (T2D) at an early age have an increased risk to develop neurodegenerative disorders, as Alzheimer’s (AD) and Parkinson’s Disease (PD). A common characteristic between T2D and these neurodegenerative disorders is the development of an insulin resistance state. Considering that the therapeutics that exists to neurodegenerative disorders only attenuate the symptoms and have several side effects, it is important to search for novel disease modifying therapies. Recently, Conde’s group showed that in states of insulin resistance, glucose intolerance and obesity, features associated with T2D, the carotid bodies (CBs) were overactivated. The CBs are peripheral chemoreceptors classically defined as oxygen sensors, and in the last years they havebeen described as metabolic sensors. Moreover, when CBs activity was abolished via the resection of the carotid sinus nerve (CSN), which transmits the information from the CBs to the brain, T2D dysmetabolic features were reverted. Considering that dysmetabolism is a risk factor to the development of neurodegenerative disorders, the main goal of this project was to investigate if the abolishment of CBs activity via bilateral resection of the CSN could prevent/ameliorate the neurodegenerative process, and cognitive impairment associated with brain insulin resistance. For that, we have used an animal model of dysmetabolism, the high fat-high sucrose (HFHSu) diet animal and tested the effect of the abolishment of CBs activity, through the resection of the CSN, on whole-body glucose metabolism and on the behavioural activity of the animals. Moreover, the levels of insulin signalling- related proteins, synaptic and neurodegenerative markers in prefrontal cortex and in the hippocampus were evaluated. We observed that the HFHSu animals exhibited impaired cognitive and olfactory functionsevaluated by the y-maze and the block tests. In contrast, the CSN resection prevented this phenotype in the y-maze test. Additionally, HFHSu diet led to an increase in the levels of advanced glycation end products (AGEs), and the amyloid precursor protein (APP) in the hippocampus, while the CSN resection attenuating this second effect. In the prefrontal cortex, it was observed an increase in the levels of alpha-synuclein (aSyn), and APP, effects abolished by CSN resection. In conclusion, this project demonstrate that CBs modulation might have a role in preventing neurodegenerative processes associated with insulin resistance.
There are no comments for this item.